Fzata
Pre-clinicalFzata, Inc. is a preclinical oral biologics therapeutics company. Fzata's proprietary Bioengineered Probiotic Yeast Medicines (BioPYM®) modality uses live yeast to make therapeutics on target in the gut to treat gastrointestinal disorders.
Founded
2018
Focus
AntibodiesBiologics
About
Fzata, Inc. is a preclinical oral biologics therapeutics company. Fzata's proprietary Bioengineered Probiotic Yeast Medicines (BioPYM®) modality uses live yeast to make therapeutics on target in the gut to treat gastrointestinal disorders.
Funding History
22Total raised: $35.8M
Grant$2.1MNINDSAug 29, 2024
Grant$923KNIAIDAug 10, 2023
Series A$15MUndisclosedJun 15, 2023
Grant$951KNIDDKApr 14, 2023
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile